Skip to main content
Erschienen in: Medical Oncology 3/2012

01.09.2012 | Original Paper

Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis

verfasst von: Jian-Feng Zhang, Zhen-Biao Mao, Zeng-Li Li, Shi-Min Xue, Hui-Jun Zhu, Hong Zhang, Run-Zhou Ni

Erschienen in: Medical Oncology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The molecular mechanisms leading to gastric carcinogenesis still remain unclear. Recently, several studies demonstrated that over-expression of guanylyl cyclase C (GCC) has been detected in intestinal-type gastric cancer (GC) and precursor lesions. Our objective was to explore the expression levels of GCC and endogenous ligands guanylin (GN) and uroguanylin (UGN) and the correlation between Helicobacter pylori (H. pylori) and GCC, GN, and UGN expressions in patients at different stages from normal mucosa to superficial gastritis, atrophic gastritis, intestinal metaplasia (IM), dysplasia, and finally adenocarcinoma. The expression of GCC and GN was absent in the distal normal gastric tissues and superficial gastritis in all cases, whereas they were measured in IM, dysplasia, and GC. The expression of GCC and GN was closely related to intestinal-type GC. From superficial gastritis to gastric carcinomas, the H. pylori positive rate was 19.7, 33.3, 69.6, 80.0, and 82.1%, respectively. The positive correlation was found between GCC and GN in IM, dysplasia, and GC. Also, the positive correlation was found between GCC, GN, and H. pylori infection in them. These results demonstrate that the detection of GCC and GN will be beneficial to diagnosis human gastric carcinoma and precancerous lesions. Ectopic expression of GCC and GN in human gastric mucosa and H. pylori infection may play an important role in the carcinogenesis of the intestinal-type GC.
Literatur
1.
Zurück zum Zitat Ebert MP, Malfertheiner P. Pathogenesis of sporadic and familial gastric cancer-implications for clinical management and cancer prevention. Aliment Pharmacol Ther. 2002;16:1059–66.PubMedCrossRef Ebert MP, Malfertheiner P. Pathogenesis of sporadic and familial gastric cancer-implications for clinical management and cancer prevention. Aliment Pharmacol Ther. 2002;16:1059–66.PubMedCrossRef
2.
Zurück zum Zitat Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.PubMedCrossRef Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–87.PubMedCrossRef
3.
Zurück zum Zitat Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques and long-term survival. Langenbecks Arch Surg. 2005;390:286–93.PubMedCrossRef Yuasa N, Nimura Y. Survival after surgical treatment of early gastric cancer, surgical techniques and long-term survival. Langenbecks Arch Surg. 2005;390:286–93.PubMedCrossRef
5.
Zurück zum Zitat Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10:720–41.PubMed Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10:720–41.PubMed
6.
Zurück zum Zitat Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449–90.PubMedCrossRef Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19:449–90.PubMedCrossRef
7.
Zurück zum Zitat Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:537–43.CrossRef Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:537–43.CrossRef
8.
Zurück zum Zitat Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut. 1997;40:701–3.PubMedCrossRef Atherton JC. The clinical relevance of strain types of Helicobacter pylori. Gut. 1997;40:701–3.PubMedCrossRef
9.
Zurück zum Zitat Cohen MB, Hawkins JA, Witte DP. Guanylin mRNA expression in human intestine and colorectal adenocarcinoma. Lab Invest. 1998;78(1):101–8 Cohen MB, Hawkins JA, Witte DP. Guanylin mRNA expression in human intestine and colorectal adenocarcinoma. Lab Invest. 1998;78(1):101–8
10.
Zurück zum Zitat Sindic A, Schlatter E. Cellular effects of guanylin and uroguanylin[J]. J Am Soc Nephrol. 2006;17:607–16.PubMedCrossRef Sindic A, Schlatter E. Cellular effects of guanylin and uroguanylin[J]. J Am Soc Nephrol. 2006;17:607–16.PubMedCrossRef
11.
Zurück zum Zitat Basu N, Arshad N, Visweswariah SS. Receptor guanylyl cyclase C (GC-C): regulation and signal transduction[J]. Mol Cell Biochem. 2010;334:67–80.PubMedCrossRef Basu N, Arshad N, Visweswariah SS. Receptor guanylyl cyclase C (GC-C): regulation and signal transduction[J]. Mol Cell Biochem. 2010;334:67–80.PubMedCrossRef
12.
Zurück zum Zitat Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–8.PubMedCrossRef
13.
Zurück zum Zitat Ding WJ, Fang JY, Chen XY, et al. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci. 2008;53:2083–9.PubMedCrossRef Ding WJ, Fang JY, Chen XY, et al. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci. 2008;53:2083–9.PubMedCrossRef
14.
Zurück zum Zitat Mao ZB, Zhang JF, Xu Z, et al. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target. J Dig Dis. 2009;10:272–85.PubMedCrossRef Mao ZB, Zhang JF, Xu Z, et al. Ectopic expression of guanylyl cyclase C in gastric cancer as a potential biomarker and therapeutic target. J Dig Dis. 2009;10:272–85.PubMedCrossRef
15.
Zurück zum Zitat Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271–90.PubMedCrossRef Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15:1271–90.PubMedCrossRef
16.
17.
Zurück zum Zitat Vinagre RM, Corvelo TC, Arnaud VC, et al. Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol. 2011;48:46–51.PubMedCrossRef Vinagre RM, Corvelo TC, Arnaud VC, et al. Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol. 2011;48:46–51.PubMedCrossRef
18.
Zurück zum Zitat Wang J, Chi DS, Kalin GB, et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002;47:107–13.PubMedCrossRef Wang J, Chi DS, Kalin GB, et al. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002;47:107–13.PubMedCrossRef
19.
Zurück zum Zitat Bornschein J, Kandulski A, Selgrad M, et al. From gastric inflammation to gastric cancer. Dig Dis. 2010;28:609–14.PubMedCrossRef Bornschein J, Kandulski A, Selgrad M, et al. From gastric inflammation to gastric cancer. Dig Dis. 2010;28:609–14.PubMedCrossRef
20.
Zurück zum Zitat Park J, Schulz S, Haaf J, et al. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2002;11:739–44.PubMed Park J, Schulz S, Haaf J, et al. Ectopic expression of guanylyl cyclase C in adenocarcinomas of the esophagus and stomach. Cancer Epidemiol Biomarkers Prev. 2002;11:739–44.PubMed
21.
Zurück zum Zitat Birbe R, Palazzo JP, Walters R, et al. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinomas of the gastrointestinal tract. Hum Pathol. 2005;36:170–9.PubMedCrossRef Birbe R, Palazzo JP, Walters R, et al. Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinomas of the gastrointestinal tract. Hum Pathol. 2005;36:170–9.PubMedCrossRef
22.
Zurück zum Zitat Hofmann F, Bernhard D, Lukowski R, et al. cGMP regulated protein kinases (cGK). Handb Exp Pharmacol. 2009;191:137–62.PubMedCrossRef Hofmann F, Bernhard D, Lukowski R, et al. cGMP regulated protein kinases (cGK). Handb Exp Pharmacol. 2009;191:137–62.PubMedCrossRef
23.
Zurück zum Zitat Mumtaz K, Abid S, Yakoob J, et al. An office-based serological test for detection of current Helicobacter pylori infection: is it useful? Eur J Gastroenterol Hepatol. 2006;18:85–8.PubMedCrossRef Mumtaz K, Abid S, Yakoob J, et al. An office-based serological test for detection of current Helicobacter pylori infection: is it useful? Eur J Gastroenterol Hepatol. 2006;18:85–8.PubMedCrossRef
24.
Zurück zum Zitat Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol. 2003;36:S37–43.PubMedCrossRef Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol. 2003;36:S37–43.PubMedCrossRef
25.
Zurück zum Zitat El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001;54:679–83.PubMedCrossRef El-Zimaity HM, Ramchatesingh J, Saeed MA, et al. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001;54:679–83.PubMedCrossRef
26.
Zurück zum Zitat Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.PubMedCrossRef Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.PubMedCrossRef
27.
Zurück zum Zitat Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004;57:177–82.PubMedCrossRef Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004;57:177–82.PubMedCrossRef
28.
Zurück zum Zitat Mann EA, Jump ML, Glenella RA. Cell line-specific transcriptional activation of the promoter of the human guanylyl cyclase C/heat-stable enterotoxin/receptor gene. Biochim Biophys Acta. 1996;1305:7–10.PubMedCrossRef Mann EA, Jump ML, Glenella RA. Cell line-specific transcriptional activation of the promoter of the human guanylyl cyclase C/heat-stable enterotoxin/receptor gene. Biochim Biophys Acta. 1996;1305:7–10.PubMedCrossRef
29.
Zurück zum Zitat Swenson ES, Mann EA, Jump ML, et al. Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor. Am J Physiol. 1999;276:G728–36.PubMed Swenson ES, Mann EA, Jump ML, et al. Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor. Am J Physiol. 1999;276:G728–36.PubMed
30.
Zurück zum Zitat Park J, Schulz S, Waldman SA. Intestine-specific activity of the human guanylyl cyclase C promoter is regulated by Cdx2. Gastroenterology. 2000;119:89–96.PubMedCrossRef Park J, Schulz S, Waldman SA. Intestine-specific activity of the human guanylyl cyclase C promoter is regulated by Cdx2. Gastroenterology. 2000;119:89–96.PubMedCrossRef
31.
Zurück zum Zitat Debruyne PR, Witek M, Gong L, et al. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappa B and Cdx2 in human esophageal cells. Gastroenterology. 2006;130:1191–206.PubMedCrossRef Debruyne PR, Witek M, Gong L, et al. Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappa B and Cdx2 in human esophageal cells. Gastroenterology. 2006;130:1191–206.PubMedCrossRef
Metadaten
Titel
Ectopic expression of guanylyl cyclase C and endogenous ligand guanylin correlates significantly with Helicobacter pylori infection in gastric carcinogenesis
verfasst von
Jian-Feng Zhang
Zhen-Biao Mao
Zeng-Li Li
Shi-Min Xue
Hui-Jun Zhu
Hong Zhang
Run-Zhou Ni
Publikationsdatum
01.09.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 3/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-0067-x

Weitere Artikel der Ausgabe 3/2012

Medical Oncology 3/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.